Emmy Ludwig

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi Feasibility and yield of screening in relatives from familial pancreatic cancer families
    Emmy Ludwig
    Gastroenterology and Nutrition Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Am J Gastroenterol 106:946-54. 2011
  2. ncbi Allergies, obesity, other risk factors and survival from pancreatic cancer
    Sara H Olson
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Cancer 127:2412-9. 2010
  3. ncbi Including additional controls from public databases improves the power of a genome-wide association study
    Semanti Mukherjee
    Gerstner Sloan Kettering Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, USA
    Hum Hered 72:21-34. 2011
  4. ncbi Allergies, variants in IL-4 and IL-4R alpha genes, and risk of pancreatic cancer
    Sara H Olson
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Cancer Detect Prev 31:345-51. 2007
  5. ncbi Studying cancer in minorities: a look at the numbers
    Sara H Olson
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cancer 117:2762-9. 2011
  6. ncbi An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions
    Maeve A Lowery
    Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Oncologist 16:1397-402. 2011

Collaborators

Detail Information

Publications6

  1. ncbi Feasibility and yield of screening in relatives from familial pancreatic cancer families
    Emmy Ludwig
    Gastroenterology and Nutrition Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Am J Gastroenterol 106:946-54. 2011
    ..In this study, we investigate whether screening at-risk relatives of familial pancreatic cancer (FPC) patients is safe and has significant yield...
  2. ncbi Allergies, obesity, other risk factors and survival from pancreatic cancer
    Sara H Olson
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Cancer 127:2412-9. 2010
    ..62, 95% CI: 0.76-3.44). The mechanisms underlying the association between history of allergies and improved survival are unknown. These novel results need to be confirmed in other studies...
  3. ncbi Including additional controls from public databases improves the power of a genome-wide association study
    Semanti Mukherjee
    Gerstner Sloan Kettering Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, USA
    Hum Hered 72:21-34. 2011
    ..Thus, through an empirical approach, this report provides practical guidance for using additional controls from publicly available datasets...
  4. ncbi Allergies, variants in IL-4 and IL-4R alpha genes, and risk of pancreatic cancer
    Sara H Olson
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Cancer Detect Prev 31:345-51. 2007
    ..Although genes have been identified that are critical in allergic response, polymorphisms in these genes have not been studied in relation to risk of pancreatic cancer. We hypothesized that variants in these genes are related to risk...
  5. ncbi Studying cancer in minorities: a look at the numbers
    Sara H Olson
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cancer 117:2762-9. 2011
    ..The authors aimed to understand how population characteristics affect the numbers of minority cancer cases in Surveillance, Epidemiology, and End Results (SEER) regions...
  6. ncbi An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions
    Maeve A Lowery
    Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Oncologist 16:1397-402. 2011
    ....